2015 ICD-9-CM Diagnosis Code 425.3
Endocardial fibroelastosis
- 2015
- Billable Thru Sept 30/2015
- Non-Billable On/After Oct 1/2015
- ICD-9-CM 425.3 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 425.3 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM:
425.3 converts directly to:
- 2015/16 ICD-10-CM I42.4 Endocardial fibroelastosis
Approximate Synonyms
- Cardiomyopathy restrictive, endocardial fibroelastosis
- Cardiomyopathy, restrictive, due to endocardial fibroelastosis
- Congenital endocardial fibroelastosis
- Congenital endocardial fibroelastosis (at birth)
- Endocardial fibroelastosis, congenital
- Primary endocardial fibroelastosis
- Primary endocardial fibroelastosis (heart condition)
- Restrictive cardiomyopathy secondary to endocardial fibroelastosis
Clinical Information
- A condition characterized by the thickening of endocardium due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (cardiomyopathy, restrictive). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (heart defects congenital;) infection; or gene mutation. Defects in the tafazzin protein, encoded by taz gene, result in a form of autosomal dominant familial endocardial fibroelastosis
- A rare disorder characterized by diffuse thickening of the endocardium. It presents with unexplained heart failure
- Condition characterized by hypertrophy of the wall of the left ventricle and conversion of the endocardium into a thick fibroelastic coat, with the capacity of the ventricle sometimes reduced, but often increased
heart 746.9
auricle 746.9
